Mimedx (MDXG) Enterprise Value (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.82% |
| Dec 31, 2025 | -16.92% |
| Sep 30, 2025 | -19.53% |
| Jun 30, 2025 | -11.69% |
| Mar 31, 2025 | -1.93% |
| Dec 31, 2024 | -17.58% |
| Sep 30, 2024 | -28.63% |
| Jun 30, 2024 | -42.38% |
| Mar 31, 2024 | 40.87% |
| Jun 30, 2023 | -12.14% |
| Mar 31, 2023 | 7.17% |
| Dec 31, 2022 | 9.93% |
| Sep 30, 2022 | -0.99% |
| Jun 30, 2022 | 4.19% |
| Mar 31, 2022 | 13.10% |
| Dec 31, 2021 | 3.89% |
| Sep 30, 2021 | -6.59% |
| Jun 30, 2021 | -0.31% |
| Mar 31, 2021 | 11.55% |
| Dec 31, 2020 | 12.58% |
| Sep 30, 2020 | -127.38% |
| Jun 30, 2020 | 9.91% |
| Mar 31, 2020 | 22.54% |
| Dec 31, 2019 | 26.62% |
| Sep 30, 2019 | 2.87% |
| Jun 30, 2019 | -241.43% |
| Mar 31, 2019 | 37.10% |
| Dec 31, 2017 | 24.77% |
| Sep 30, 2017 | 23.16% |
| Jun 30, 2017 | -53.71% |
| Mar 31, 2017 | -1.99% |
| Dec 31, 2016 | -65.35% |
| Sep 30, 2016 | 22.96% |
| Jun 30, 2016 | -35.11% |
| Mar 31, 2016 | 39.88% |
| Dec 31, 2015 | 38.41% |
| Sep 30, 2015 | -3.76% |
| Jun 30, 2015 | -2.58% |
| Mar 31, 2015 | 14.59% |
| Dec 31, 2014 | -10.75% |
| Sep 30, 2014 | -20.40% |
| Jun 30, 2014 | 8.77% |
| Mar 31, 2014 | 2.40% |
| Dec 31, 2013 | -627.15% |
| Sep 30, 2013 | -44.55% |
| Jun 30, 2013 | 26.75% |
| Mar 31, 2013 | 15.23% |
| Dec 31, 2012 | 11.38% |
| Sep 30, 2012 | -187.08% |
| Jun 30, 2012 | 12.13% |
| Mar 31, 2012 | 26.54% |
| Dec 31, 2011 | -545.49% |
| Sep 30, 2011 | 60.53% |
| Jun 30, 2011 | -58.19% |
| Mar 31, 2011 | 23.89% |